ScholarIQanswers from OpenAlex
Polycystic Kidney Disease Foundation
InstitutionResearch output, impact & collaborations
Polycystic Kidney Disease Foundation is a institution indexed in ScholarIQ from OpenAlex.
What is known about Polycystic Kidney Disease Foundation?
ScholarIQrecord summary
Polycystic Kidney Disease Foundation is a research organisation in Kansas City, US. OpenAlex records 25 works and 1,226 citations for it.
How many works does Polycystic Kidney Disease Foundation have?
ScholarIQindexed works
Polycystic Kidney Disease Foundation has 25 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Polycystic Kidney Disease Foundation have?
ScholarIQcitation count
Polycystic Kidney Disease Foundation has 1,226 citations in the OpenAlex counts ScholarIQ stores.
What is the average h-index at Polycystic Kidney Disease Foundation?
ScholarIQavg h-index
Polycystic Kidney Disease Foundation has an average h-index of 31 in OpenAlex.
What is the ROR of Polycystic Kidney Disease Foundation?
ScholarIQror
The ROR for Polycystic Kidney Disease Foundation is on the source record.
What is the OpenAlex record for Polycystic Kidney Disease Foundation?
ScholarIQopenalex
The OpenAlex for Polycystic Kidney Disease Foundation is on the source record.
Who are the most-cited researchers behind Polycystic Kidney Disease Foundation?
ScholarIQtop researchers by citations
What are the most-cited papers on Polycystic Kidney Disease Foundation?
ScholarIQmost cited works
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
Philip Kam‐Tao Li, Kai Ming Chow, Yeoungjee Cho, Stanley Fan, Ana Elizabeth Figueiredo, Tess Harris, Talerngsak Kanjanabuch, Yong-Lim Kim, Magdalena Madero, Jolanta Małyszko, Rajnish Mehrotra, Ikechi G. Okpechi, Jeff Perl, Beth Piraino, Naomi Runnegar, Isaac Teitelbaum, Jennifer Ka-Wah Wong, Xueqing Yu, David W. Johnson
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt, Ron T. Gansevoort, Tess Harris, Shigeo Horie, Bertram L. Kasiske, Dwight Odland, York Pei, Ronald D. Perrone, Yves Pirson, Robert W. Schrier, Roser Torrá, Vicente E. Torres, Terry Watnick, David C. Wheeler
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey
Nicole Evangelidis, Allison Tong, Braden Manns, Brenda R. Hemmelgarn, David C. Wheeler, Peter Tugwell, Sally Crowe, Tess Harris, Wim Van Biesen, Wolfgang C. Winkelmayer, Bénédicte Sautenet, Donal O’Donoghue, Helen Tam‐Tham, Sajeda Youssouf, Sreedhar Mandayam, Angela Ju, Carmel M. Hawley, Carol A. Pollock, David C.H. Harris, David W. Johnson, Dena E. Rifkin, Francesca Tentori, John Agar, Kevan R. Polkinghorne, Martin Gallagher, Peter G. Kerr, Stephen P. McDonald, Kirsten Howard, Martin Howell, Jonathan C. Craig
Patient-centred approaches for the management of unpleasant symptoms in kidney disease
Kamyar Kalantar‐Zadeh, Mark B. Lockwood, Connie M. Rhee, Ekamol Tantisattamo, Sharon Andreoli, Alessandro Balducci, Paul Laffin, Tess Harris, Richard Knight, Latha Kumaraswami, Vassilios Liakopoulos, Siu‐Fai Lui, Sajay Kumar, Maggie Ng, Gamal Saadi, Ifeoma Ulasi, Allison Tong, Philip Kam‐Tao Li
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
Charlotte Gimpel, Carsten Bergmann, Detlef Böckenhauer, Luc Breysem, Melissa A. Cadnapaphornchai, Metin Cetiner, Jan Dudley, Francesco Emma, Martin Konrad, Tess Harris, Peter C. Harris, Jens König, Max C. Liebau, Matko Marlais, Djalila Mekahli, Alison Metcalfe, Jun Oh, Ronald D. Perrone, Manish D. Sinha, Andrea Titieni, Roser Torrá, Stefanie Weber, Paul J.D. Winyard, Franz Schaefer
How much of the research on Polycystic Kidney Disease Foundation is open access?
ScholarIQopen access share
90%OPEN ACCESS